[av_section min_height=” min_height_pc=’25’ min_height_px=’500px’ padding=’default’ shadow=’no-border-styling’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=” bottom_border_style=” custom_margin=’0px’ custom_margin_sync=’true’ custom_arrow_bg=” id=” color=’main_color’ background=’bg_color’ custom_bg=’#08b4a0′ background_gradient_color1=” background_gradient_color2=” background_gradient_direction=’vertical’ src=” attachment=” attachment_size=” attach=’parallax’ position=’top center’ repeat=’stretch’ video=” video_ratio=’16:9′ overlay_opacity=’0.5′ overlay_color=’#08b4a0′ overlay_pattern=” overlay_custom_pattern=” av_element_hidden_in_editor=’0′ av_uid=’av-jzkylawd’ custom_class=”]
\n[av_heading heading=’VALUE-Dx Summary October 2019 Update’ tag=’h3′ link_apply=” link=’manually,http:\/\/’ link_target=” style=’blockquote modern-quote modern-centered’ size=” subheading_active=’subheading_below’ subheading_size=’15’ margin=” margin_sync=’true’ padding=’10’ color=” custom_font=” av-medium-font-size-title=” av-small-font-size-title=” av-mini-font-size-title=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” av_uid=’av-k1j7pf4p’ custom_class=” admin_preview_bg=”][\/av_heading]<\/p>\n
[av_codeblock wrapper_element=” wrapper_element_attributes=” codeblock_type=” av_uid=’av-jzkypxcu’ custom_class=”]<\/p>\n
[\/av_codeblock]
\n[\/av_section]<\/p>\n
[av_section min_height=” min_height_pc=’25’ min_height_px=’500px’ padding=’default’ shadow=’no-border-styling’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=” bottom_border_style=” custom_margin=’0px’ custom_margin_sync=’true’ custom_arrow_bg=” id=” color=’main_color’ background=’bg_color’ custom_bg=’#1b7ca4′ background_gradient_color1=” background_gradient_color2=” background_gradient_direction=’vertical’ src=” attachment=” attachment_size=” attach=’scroll’ position=’top left’ repeat=’no-repeat’ video=” video_ratio=’16:9′ overlay_opacity=’0.9′ overlay_color=” overlay_pattern='{{AVIA_BASE_URL}}images\/background-images\/dots-for-dark-background.png’ overlay_custom_pattern=” av_element_hidden_in_editor=’0′ av_uid=’av-1cjng’ custom_class=”]
\n[av_one_full first min_height=” vertical_alignment=’av-align-top’ space=” margin=’0px’ margin_sync=’true’ row_boxshadow_color=” row_boxshadow_width=’10’ link=” linktarget=” link_hover=” title_attr=” alt_attr=” padding=’50px,5%,50px,5%’ highlight_size=’1.1′ border=” border_color=” radius=’0px’ radius_sync=’true’ column_boxshadow_color=” column_boxshadow_width=’10’ background=’bg_color’ background_color=” background_gradient_color1=” background_gradient_color2=” background_gradient_direction=’vertical’ src=” attachment=” attachment_size=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=” av_uid=’av-k0i4yzrj’ custom_class=”]<\/p>\n
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” av_uid=’av-yfjs’ custom_class=” admin_preview_bg=”] Whilst the web-based PPAS will record information about patients seeking healthcare for CA-ARTI, the PRUDENCE trial will evaluate clinical algorithms that incorporate a point of care test for CA-ARTI.<\/p>\n Furthermore, this summary provides an update on the activities that have already begun during the first year of VALUE-Dx.<\/p>\n
\nThis summary provides more information on the future work that VALUE-Dx will carry out in the coming years across 20 European countries<\/strong> on community-acquired acute respiratory tract infections (CA-ARTI). This includes details the three winter seasons from 2019 to 2022:<\/p>\n\n